Evidence in support of this is seen by the fact that one of the main routes by which cMYC drives tumourigenesis is through inhibition of differentiation and it has been shown to antagonize differentiation and growth inhibition effects of p27Kip1 in leukaemia cells [42]. The gene discussed is CDKN1B; the disease is leukemia.